Matinas Financial Statements From 2010 to 2026

Matinas BioPharma Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 13.8 M 14.5 M 22.7 M Slightly volatile Other Current Liabilities 1.6 M 2.1 M 1.3 M Slightly volatile Total Current Liabilities 2.6 M 3.1 M 2.1 M Slightly volatile Total Stockholder Equity 8.3 M 8.7 M 16.7 M Slightly volatile Accounts Payable 103.8 K 109.2 K 359.2 K Pretty Stable Cash 9.8 M 8.4 M 7.9 M Slightly volatile Cash And Short Term Investments 8 M 8.4 M 14.4 M Slightly volatile Common Stock Shares Outstanding 4.2 M 4.4 M 11.4 M Very volatile Total Liabilities 7.7 M 5.8 M 6.2 M Slightly volatile Total Current Assets 8.8 M 9.2 M 15.5 M Slightly volatile Common Stock 1.1 K 1.1 K 8.6 K Slightly volatile Property Plant And Equipment Net 3.1 M 2.5 M 2.3 M Slightly volatile Non Current Assets Total 10.4 M 5.3 M 7.6 M Slightly volatile Common Stock Total Equity 13 K 25.3 K 12.4 K Slightly volatile Liabilities And Stockholders Equity 13.8 M 14.5 M 24.6 M Slightly volatile Other Current Assets 1.6 M 852.1 K 1.2 M Slightly volatile Other Stockholder Equity 250.5 M 238.5 M 106.7 M Slightly volatile Property Plant And Equipment Gross 3.5 M 4.8 M 2.7 M Slightly volatile Short and Long Term Debt Total 2.4 M 3.3 M 1.8 M Slightly volatile Other Assets 2.9 M 3.7 M 2.2 M Slightly volatile Long Term Debt 130 K 123.8 K 69.6 K Slightly volatile Long Term Debt Total 57.6 K 62.7 K 43.1 K Slightly volatile Non Current Liabilities Total 2.6 M 2.7 M 3.9 M Slightly volatile Capital Surpluse 229.5 M 218.6 M 103.4 M Slightly volatile Capital Lease Obligations 2.6 M 3.3 M 1.7 M Slightly volatile Deferred Long Term Liabilities 291.6 K 306.9 K 1.5 M Slightly volatile Long Term Investments 132.7 K 103.8 K 145.4 K Slightly volatile Short and Long Term Debt 123 K 229.8 K 138.2 K Slightly volatile Short Term Debt 924.9 K 880.9 K 359.1 K Slightly volatile Property Plant Equipment 2.3 M 2.4 M 1.7 M Slightly volatile Other Liabilities 291.6 K 306.9 K 814.1 K Slightly volatile Intangible Assets 2.4 M 2 M 2.9 M Slightly volatile Preferred Stock Total Equity 4.7 M 3.4 M 5.2 M Slightly volatile Non Current Liabilities Other 3.1 M 4.1 M 2.5 M Slightly volatile Net Invested Capital 8.3 M 8.7 M 15.9 M Slightly volatile Net Working Capital 5.9 M 6.2 M 14.6 M Slightly volatile Capital Stock 855 900 5.6 M Slightly volatile Net Receivables 520 K 585 K 638.5 K Slightly volatile
Matinas BioPharma Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 1.2 M 1.1 M 368.5 K Slightly volatile Selling General Administrative 7.6 M 10 M 6.3 M Slightly volatile Other Operating Expenses 17.7 M 28.3 M 15 M Slightly volatile Research Development 9.7 M 13.1 M 8.1 M Slightly volatile Total Operating Expenses 29.7 M 28.3 M 12.4 M Slightly volatile Cost Of Revenue 1.1 M 1.1 M 7.1 M Pretty Stable Non Operating Income Net Other 4.3 M 4.1 M 1.5 M Slightly volatile Interest Income 653.6 K 622.5 K 278.6 K Slightly volatile Reconciled Depreciation 749.8 K 1.1 M 472 K Slightly volatile Preferred Stock And Other Adjustments 437.2 K 356.2 K 662.1 K Slightly volatile Selling And Marketing Expenses 752.8 K 846.9 K 924.4 K Slightly volatile
Matinas BioPharma Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Begin Period Cash Flow 9.4 M 5.8 M 7.4 M Slightly volatile Other Non Cash Items 5.3 M 5.1 M 1.2 M Slightly volatile End Period Cash Flow 10 M 8.7 M 8.1 M Slightly volatile Stock Based Compensation 3.5 M 3.7 M 2.7 M Slightly volatile Depreciation 1.2 M 1.1 M 464.7 K Slightly volatile Change To Account Receivables 36.5 K 41.1 K 44.8 K Slightly volatile Change To Netincome 3.6 M 6 M 3.4 M Slightly volatile Change Receivables 36.5 K 41.1 K 44.8 K Slightly volatile Dividends Paid 1.2 B 759.2 M 2.4 B Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 36.64 38.57 896 Pretty Stable Dividend Yield 2.79 2.93 24.8322 Slightly volatile PTB Ratio 0.36 0.38 10.6943 Slightly volatile Book Value Per Share 1.33 1.4 6.3758 Very volatile Average Payables 351.3 K 579.1 K 450.8 K Slightly volatile Stock Based Compensation To Revenue 3.86 4.06 19.9952 Pretty Stable Capex To Depreciation 0.25 0.27 21.5191 Slightly volatile PB Ratio 0.36 0.38 10.6943 Slightly volatile EV To Sales 35.68 37.56 834 Pretty Stable Payables Turnover 14.97 24.29 19.8793 Slightly volatile Sales General And Administrative To Revenue 8.09 8.52 47.9217 Very volatile Research And Ddevelopement To Revenue 11.3 11.9 61.9347 Pretty Stable Capex To Revenue 0.22 0.23 1.9396 Very volatile Cash Per Share 1.64 1.72 5.6092 Very volatile Days Payables Outstanding 14.78 15.55 211 Pretty Stable Income Quality 0.59 0.655 0.697 Pretty Stable Intangibles To Total Assets 0.23 0.21 0.3035 Slightly volatile Net Debt To EBITDA 0.25 0.26 0.9942 Slightly volatile Current Ratio 2.57 2.71 6.2192 Very volatile Tangible Book Value Per Share 0.94 0.99 5.2264 Very volatile Shareholders Equity Per Share 1.33 1.4 6.3758 Very volatile Debt To Equity 0.36 0.34 0.1094 Slightly volatile Capex Per Share 0.0548 0.0577 0.1793 Slightly volatile Revenue Per Share 0.14 0.23 0.1793 Pretty Stable Interest Debt Per Share 0.47 0.54 0.4617 Slightly volatile Debt To Assets 0.22 0.21 0.0724 Slightly volatile Price Book Value Ratio 0.36 0.38 10.6943 Slightly volatile Days Of Payables Outstanding 14.78 15.55 211 Pretty Stable Ebt Per Ebit 1.05 1.14 0.9742 Pretty Stable Effective Tax Rate 0.0036 0.0038 0.0142 Slightly volatile Company Equity Multiplier 1.1 1.5 1.3471 Pretty Stable Long Term Debt To Capitalization 0.79 0.89 0.9735 Slightly volatile Total Debt To Capitalization 0.26 0.25 0.0879 Slightly volatile Debt Equity Ratio 0.36 0.34 0.1094 Slightly volatile Quick Ratio 2.57 2.71 6.2192 Very volatile Net Income Per E B T 0.78 0.9 0.9674 Slightly volatile Cash Ratio 4.65 3.14 4.2834 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.13 1.17 1.0476 Slightly volatile Price To Book Ratio 0.36 0.38 10.6943 Slightly volatile Fixed Asset Turnover 0.15 0.2 0.2785 Slightly volatile Debt Ratio 0.22 0.21 0.0724 Slightly volatile Price Sales Ratio 36.64 38.57 896 Pretty Stable Asset Turnover 0.0413 0.0393 0.0223 Slightly volatile Price Fair Value 0.36 0.38 10.6943 Slightly volatile
Matinas BioPharma Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 2.7 M 2.9 M 155.8 M Slightly volatile

Matinas Fundamental Market Drivers

Matinas Upcoming Events

About Matinas BioPharma Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Matinas BioPharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Matinas BioPharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Matinas Biopharma Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Matinas Biopharma Holdings Stock:

How To Invest In Matinas Details

Is Matinas Stock a good investment? Details

What is Matinas BioPharma's Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details